Charles Comins
Impact in
- Biotechnology top 10%
- Cancer Research and Treatments
-
- Virus-based gene therapy research
Papers in
-
- Lung Cancer Treatments and Mutations 6
- Lung Cancer Diagnosis and Treatment 4
- Pleural and Pulmonary Diseases 3
- Occupational and environmental lung diseases 3
- Oncology 6
- Co-authors
- Alan Melcher (3 shared papers)Kevin J. Harrington (3 shared papers)Hardev Pandha (3 shared papers)Victoria Roulstone (2 shared papers)Andrew Protheroe (1 shared paper)Mitch A. Phelps (1 shared paper)Lucy Heinemann (1 shared paper)K.L. Mettinger (1 shared paper)
- Journals
- BMJ Open (2 papers)Clinical Oncology (2 papers)British journal of surgery (2 papers)Lung Cancer (2 papers)British Journal of Cancer (1 paper)
- Partner nations
- United KingdomSwitzerlandItaly
In The Last Decade
Charles Comins
18 papers receiving 247 citations
Peers
Comparison fields: 5 of 49
- Biotechnology 55
- Genetics 148
- Oncology 115
- Infectious Diseases 64
- Cancer Research 41
Countries citing papers authored by Charles Comins
This map shows the geographic impact of Charles Comins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Comins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Comins more than expected).
Fields of papers citing papers by Charles Comins
This network shows the impact of papers produced by Charles Comins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Comins. The network helps show where Charles Comins may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles Comins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 109 | |
| 2 | 2008 | 39 | |
| 3 | 2016 | 22 | |
| 4 | 2022 | 21 | |
| 5 | 2018 | 9 | |
| 6 | 2021 | 6 | |
| 7 | 2018 | 6 | |
| 8 | 2023 | 6 | |
| 9 | 2014 | 6 | |
| 10 | 2018 | 5 | |
| 11 | 2022 | 5 | |
| 12 | 2007 | 4 | |
| 13 | 2024 | 3 | |
| 14 | 2022 | 3 | |
| 15 | 2023 | 3 | |
| 16 | A prospective multi-centre study of the impact of Oncotype DX (R) on adjuvant treatment decisions in patients in the UK with estrogen receptor positive early breast cancer | 2013 | 1 |
| 17 | 2024 | 1 | |
| 18 | 2014 | 1 | |
| 19 | 2024 | 0 |
About Charles Comins
Charles Comins is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Surgery and Genetics, having authored 19 papers that have together received 250 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (4 papers), Pleural and Pulmonary Diseases (3 papers), Virus-based gene therapy research (3 papers), Breast Implant and Reconstruction (3 papers), Occupational and environmental lung diseases (3 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Biotechnology (55 citations), Genetics (148 citations), Oncology (115 citations), Infectious Diseases (64 citations) and Cancer Research (41 citations). Charles Comins has collaborated with scholars based in United Kingdom, Switzerland and Italy. Frequent co-authors include Alan Melcher, Kevin J. Harrington, Hardev Pandha, Victoria Roulstone, Andrew Protheroe, Mitch A. Phelps, Lucy Heinemann, K.L. Mettinger, Katie Twigger and Matt Coffey. Their work appears in journals such as BMJ Open, Clinical Oncology, British journal of surgery, Lung Cancer and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.